KELLI DUCRAY: Open Payments
NPI 1306338736 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 24 payments from 13 companies in 2025. Trend: 2023 $376 · 2024 $42 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 2 | $151 |
| Medtronic, Inc. | 1 | $129 |
| Merck Sharp & Dohme LLC | 3 | $83 |
| Alnylam Pharmaceuticals Inc. | 4 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Impulse Dynamics (USA) Inc. | 3 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
Products named: SYMPLICITY G3, UPTRAVI, AMVUTTRA, Kerendia, VERQUVO, Optimizer, LEQVIO, CAPVAXIVE.
Industry payments across AZ — which companies pay providers there.
